Hypoxia, HIF1 and glucose metabolism in the solid tumour
The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
It has been known for many years that cellular metabolism within the solid tumour is markedly different from that of the corresponding normal tissue. The transcription factor hypoxia-inducible factor 1 (HIF1) has been implicated in regulating many of the genes that are responsible for the metabolic difference. However, it remains unclear how this 'aerobic glycolysis', originally described by Otto Warburg, offers tumour cells a growth advantage. As discussed in this Perspective, new data suggests that this metabolic switch may provide a benefit to the tumour not by increasing glycolysis but by decreasing mitochondrial activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activated HIF-1 plays a crucial role in adaptive responses of the tumor cells to changes in oxygen through transcriptional activation of over 100 downstream genes which regulate vital biological processes required for tumor survival and progression.”
From HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) · cites this paper as [3]
In the citing paper
“HIF-1 mediates this metabolic conversion through the induction of enzymes involved in the glycolysis pathway and overexpression of glucose transporters (GLUTs) which increase glucose import into tumor cells3.”
From HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) · cites this paper as [3]
In the citing paper
“HIF-1α is activated due to blockade of its degradation pathway mediated by low oxygen levels, thereby increasing the expression of target genes, including those encoding glycolytic enzymes and glucose transporters, and increasing lactate secretion67.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [67]
Citations
Cites
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662 · cited 1×
“Tumour cells respond to these conditions, and adapt their metabolism to adjust the O 2 demand to meet the limited suppl”
Background
Cited by
Items 401–500 of 1,002
Nitrogen anabolism underlies the importance of glutaminolysis in proliferating cells
Meng, M., Chen, S., Lao, T., Liang, D., & Sang, N. (2010) · Cell Cycle · doi:10.4161/cc.9.19.13139 · Cited by 86
Zhong, X., Wang, X., Zhou, T., Jin, Y., Tan, S., Chen, J., Geng, X., Li, N., Shi, H., Zeng, Q., et al. (2017) · Marine Biotechnology · doi:10.1007/s10126-017-9757-5 · Cited by 97
Pathologic HIF1α signaling drives adipose progenitor dysfunction in obesity
Shao, M., Hepler, C., Zhang, Q., Shan, B., Vishvanath, L., Henry, G. H., Zhao, S., An, Y., Wu, Y., Strand, D. W., et al. (2021) · Cell stem cell · doi:10.1016/j.stem.2020.12.008 · Cited by 91
Dong, Z., Wang, C., Gong, Y., Zhang, Y., Fan, Q., Hao, Y., Li, Q., Wu, Y., Zhong, X., Yang, K., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c02688 · Cited by 88
Cheng, J., Gu, Jin, Cheng, S. H., & Wong, W. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s25162 · Cited by 87
Wen, Y., Xiong, X., Scott, T. L., Li, A. T., Wang, C., Weiss, H. L., Tan, L., Bradford, E. M., Fan, T. W. ‐., Chandel, N. S., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-018-0265-6 · Cited by 89
Oxygen Sensing in Retinal Health and Disease
Lange, C. A. K., & Bainbridge, J. W. B. (2012) · Ophthalmologica · doi:10.1159/000331418 · Cited by 86
Prosser, G. A., Brandenburg, J., Reiling, N., Barry, C. E., Wilkinson, R. J., & Wilkinson, K. A. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2016.10.001 · Cited by 100
Yuen, C., Asuthkar, S., Guda, M. R., Tsung, A. J., & Velpula, K. K. (2016) · CNS Oncology · doi:10.2217/cns-2015-0006 · Cited by 85
Molecular insights and novel approaches for targeting tumor metastasis
Das, S. S., Alkahtani, S. H., Bharadwaj, P., Ansari, M. T., Alkahtani, M. D. F., Pang, Z., Hasnain, M. S., Nayak, A. K., & Aminabhavi, T. M. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119556 · Cited by 87
Sharma, A., Sinha, S., & Shrivastava, N. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.849040 · Cited by 93
Application of genomics, Proteomics and Metabolomics in Drug discovery, Development and Clinic
Russell, C. A., Rahman, A., & Mohammed, A. R. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.4 · Cited by 97
Li, P., Zhang, D., Shen, L., Dong, K., Wu, M., Ou, Z., & Shi, D. (2016) · Scientific Reports · doi:10.1038/srep22831 · Cited by 91
Sakamoto, T., Niiya, D., & Seiki, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.188714 · Cited by 93
Regulation of Sialyl Lewis Antigen Expression in Colon Cancer Cells by Sialidase NEU4
Shiozaki, K., Yamaguchi, K., Takahashi, K., Moriya, S., & Miyagi, T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.231191 · Cited by 81
Song, J. H., Ge, Z., Yang, X., Luo, Q. F., Wang, C., You, H., Ge, T., Deng, Y., Lin, H., Cui, Y., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.10.021 · Cited by 92
MYC and HIF in shaping immune response and immune metabolism
Gnanaprakasam, J. R., Sherman, J. W., & Wang, R. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.03.004 · Cited by 86
Hu, M., Fu, Q., Jing, C., Zhang, X., Qin, T., & Pan, Y. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109703 · Cited by 85
Hypoxia is a Key Driver of Alternative Splicing in Human Breast Cancer Cells
Han, J., Li, J., Ho, J. C., Chia, G. S., Kato, H., Jha, S., Yang, H. H., Poellinger, L., & Lee, K. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-04333-0 · Cited by 95
Microenvironmental control of glucose metabolism in tumors by regulation of pyruvate dehydrogenase
Golias, T., Kery, M., Radenkovic, S., & Papandreou, I. (2018) · International Journal of Cancer · doi:10.1002/ijc.31812 · Cited by 86
Dysregulation of Glucose Metabolism by Oncogenes and Tumor Suppressors in Cancer Cells
Marbaniang, C., & Kma, L. (2018) · PubMed · doi:10.22034/apjcp.2018.19.9.2377 · Cited by 79
Lactic acid induces lactate transport and glycolysis/OXPHOS interconversion in glioblastoma
Duan, K., Liu, Z.-J., Hu, S.-Q., Huo, H., Xu, Z., Ruan, J.-F., Sun, Y., Dai, L.-P., Yan, C.-B., Xiong, W., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.06.092 · Cited by 264
Lemoine, M., Derenzini, E., Buglio, D., Medeiros, L. J., Davis, R. E., Zhang, J., Ji, Y., & Younes, A. (2012) · Blood · doi:10.1182/blood-2011-01-331421 · Cited by 82
Mitochondrial remodeling in cancer metabolism and survival: Potential for new therapies
Barbosa, I. A., Machado, N. G., Skildum, A. J., Scott, P. M., & Oliveira, P. J. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.04.005 · Cited by 95
Dholakia, A. S., Chaudhry, M. Q., Leal, J. P., Chang, D. T., Raman, S. P., Hacker‐Prietz, A., Su, Z., Pai, J., Oteiza, K., Griffith, M. E., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.02.031 · Cited by 82
Lee, S. J., Thien Quach, C. H., Jung, K.-H., Paik, J.-Y., Lee, J. H., Park, J. W., & Lee, K.-H. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.139428 · Cited by 76
Targeting Cancer Stem Cell Redox Metabolism to Enhance Therapy Responses
Luo, M., & Wicha, M. S. (2018) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2018.10.003 · Cited by 81
Pathophysiologic Correlation Between 62Cu-ATSM and 18F-FDG in Lung Cancer
Lohith, T. G., Kudo, T., Demura, Y., Umeda, Y., Kiyono, Y., Fujibayashi, Y., & Okazawa, H. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.069021 · Cited by 86
Metabolic control analysis indicates a change of strategy in the treatment of cancer
Moreno‐Sánchez, R., Saavedra, E., Rodríguez‐Enríquez, S., Gallardo‐Pérez, J. C., Quezada, H., & Westerhoff, H. V. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.06.002 · Cited by 83
Oleksiewicz, U., Liloglou, T., Field, J. K., & Xinarianos, G. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0764-9 · Cited by 87
Prusty, B. K., Böhme, L., Bergmann, B., Siegl, C., Krause, E., Mehlitz, A., & Rudel, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047427 · Cited by 77
Piao, L., Li, Y., Kim, S. J., Byun, H. S., Huang, S. M., Hwang, S.-K., Yang, K.-J., Park, K. A., Won, M., Hong, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3235 · Cited by 79
Lu, Y., Liu, H., Bi, Y., Yang, H., Li, Y., Wang, J., Zhang, Z., Wang, Y., Li, C., Jia, A., et al. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.5 · Cited by 80
Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways
Valli, A., Rodriguez, M., Moutsianas, L., Fischer, R., Fedele, V., Huang, H.-L., Van Stiphout, R., Jones, D., Mccarthy, M., Vinaxia, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3058 · Cited by 79
Optical Detection of Single Cell Lactate Release for Cancer Metabolic Analysis
Zheng, X. T., Yang, H., & Li, C. M. (2010) · Analytical Chemistry · doi:10.1021/ac100074n · Cited by 79
Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis
Yao, W., Ji, S., Qin, Y., Yang, J., Xu, J., Zhang, B., Xu, W., Liu, J., Shi, S., Liu, L., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-187 · Cited by 80
Sun, L., Chen, Y., Kuang, S., Li, G., Guan, R., Liu, J., Ji, L., & Chao, H. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201600310 · Cited by 83
Chanmee, T., Ontong, P., Izumikawa, T., Higashide, M., Mochizuki, N., Chokchaitaweesuk, C., Khansai, M., Nakajima, K., Kakizaki, I., Kongtawelert, P., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.751263 · Cited by 79
miR-885-5p Negatively Regulates Warburg Effect by Silencing Hexokinase 2 in Liver Cancer
Xu, F., Yan, J., Gan, Y., Chang, Y., Wang, H., He, X., & Zhao, Q. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.09.002 · Cited by 82
Metabolic aspects of high‐altitude adaptation in Tibetans
Ge, R., Simonson, T. S., Gordeuk, V. R., Prchal, J. T., & McClain, D. A. (2015) · Experimental Physiology · doi:10.1113/ep085292 · Cited by 85
Swartz, J. E., Pothen, A. J., Stegeman, I., Willems, S. M., & Grolman, W. (2015) · Cancer Medicine · doi:10.1002/cam4.460 · Cited by 82
Inter‐connection between mitochondria and HIFs
Tormos, K. V., & Chandel, N. S. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01031.x · Cited by 74
Sun, H., Zhu, A., Zhou, X., & Wang, F. (2017) · Oncotarget · doi:10.18632/oncotarget.16991 · Cited by 75
Hypoxia- and MicroRNA-Induced Metabolic Reprogramming of Tumor-Initiating Cells
Ullmann, P., Nurmik, M., Begaj, R., Haan, S., & Letellier, E. (2019) · Cells · doi:10.3390/cells8060528 · Cited by 77
Yu, W., Kong, Q., Jiang, S., Li, Y., Wang, Z., Mao, Q., Zhang, X., Liu, Q., Zhang, P., Li, Y., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.169125 · Cited by 85
Eckert, A. W., Lautner, M. H. W., Schütze, A., Taubert, H. W., Schubert, J., & Bilkenroth, U. (2011) · Histopathology · doi:10.1111/j.1365-2559.2011.03806.x · Cited by 90
Seebacher, N. A., Lane, D. J. R., Richardson, D. R., & Jansson, P. J. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.201 · Cited by 82
Geng, H., Xue, C., Mendonca, J., Sun, X., Liu, Q., Reardon, P. N., Chen, Y., Qian, K., Hua, V. J., Chen, A. P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07411-7 · Cited by 82
Roy, D., Sheng, G. Y., Semukunzi, H., de Carvalho, E. L., Mahanty, A., Yuan, S., & Sun, L. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.019 · Cited by 80
Kang, S., Gil, Y., Min, D., & Jang, H. (2020) · ACS Nano · doi:10.1021/acsnano.9b09974 · Cited by 76
Hu, Y., Tang, J., Xu, F., Chen, J., Zeng, Z., Han, S., Wang, F., Wang, D., Huang, M., Zhao, Y. B., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02285-6 · Cited by 83
Sun, X., Kumar, S., Sharma, S., Aggarwal, S., Lu, Q., Gross, C., Rafikova, O., Lee, S. G., Dasarathy, S., Hou, Y., et al. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0187oc · Cited by 75
Pan, X., Zhao, Y., Cheng, T., Zheng, A., Ge, A., Zang, L., Xu, K., & Tang, B. (2019) · Chemical Science · doi:10.1039/c9sc02020a · Cited by 76
Carvalho, T. M. A., Molfetta, D. D., Greco, M. R., Koltai, T., Alfarouk, K. O., Reshkin, S. J., & Cardone, R. A. (2021) · Cancers · doi:10.3390/cancers13236135 · Cited by 82
Busato, F., Khouzai, B. E., & Mognato, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810211 · Cited by 84
FDG PET for rheumatoid arthritis: basic considerations and whole‐body PET/CT
Kubota, K., Ito, K., Morooka, M., Minamimoto, R., Miyata, Y., Yamashita, H., Takahashi, Y., & Mimori, A. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06031.x · Cited by 75
EglN2 associates with the NRF 1‐ PGC 1α complex and controls mitochondrial function in breast cancer
Zhang, J., Wang, C., Chen, X., Takada, M., Fan, C., Zheng, X., Wen, H., Liu, Y., Wang, C., Pestell, R. G., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201591437 · Cited by 72
Metabolic Features of Multiple Myeloma
El Arfani, C., De Veirman, K., Maes, K., De Bruyne, E., & Menu, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041200 · Cited by 75
Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance
Goldman, A. J., Khiste, S., Freinkman, E., Dhawan, A., Majumder, B., Mondal, J., Pinkerton, A. B., Eton, E. O., Medhi, R., Chandrasekar, V., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aas8779 · Cited by 79
Vacuolar-ATPase Inhibition Blocks Iron Metabolism to Mediate Therapeutic Effects in Breast Cancer
Schneider, L. S., von Schwarzenberg, K., Lehr, T., Ulrich, M. P., Kubisch-Dohmen, R., Liebl, J., Trauner, D. H., Menche, D., & Vollmar, A. M. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2097 · Cited by 81
Hong, S.-P., Cw, P., Kim, S. W., Nam, Y. J., Yu, J. H., Shin, J. H., Yun, C. H., Im, S., Kim, K.-T., Sung, Y. C., et al. (2015) · Oncogene · doi:10.1038/onc.2015.415 · Cited by 80
Pan, X., Song, X., Wang, C., Cheng, T., Luan, D., Xu, K., & Tang, B. (2019) · Theranostics · doi:10.7150/thno.31841 · Cited by 75
Raut, G. K., Chakrabarti, M., Pamarthy, D., & Bhadra, M. P. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.09.020 · Cited by 81
Regulation of 18F-FDG Accumulation in Colorectal Cancer Cells with Mutated KRAS
Iwamoto, M., Kawada, K., Nakamoto, Y., Itatani, Y., Inamoto, S., Toda, K., Kimura, H., Sasazuki, T., Shirasawa, S., Okuyama, H., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.142927 · Cited by 77
Legendre, C., Hori, T., Loyer, P., Aninat, C., Ishida, S., Glaise, D., Lucas‐Clerc, C., Boudjéma, K., Guguen‐Guillouzo, C., Corlu, A., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.07.010 · Cited by 76
HIF-transcribed p53 chaperones HIF-1α
Madan, E., Parker, T. M., Pelham, C. J., Palma, A. M., Peixoto, M. L., Nagane, M., Chandaria, A., Tomás, A. R., Canas‐Marques, R., Henriques, V., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz766 · Cited by 81
Multifunctional nanoreactors-integrated microneedles for cascade reaction-enhanced cancer therapy
Zhou, Y., Niu, B., Zhao, Y., Fu, J., Wen, T., Liao, K., Quan, G., Pan, X., & Wu, C. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.09.041 · Cited by 72
Warrington, J. P., Csiszar, A., Mitschelen, M., Lee, Y. W., & Sonntag, W. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030444 · Cited by 71
Galectin-3 Up-Regulation in Hypoxic and Nutrient Deprived Microenvironments Promotes Cell Survival
Ikemori, R., Machado, C. M. L., Furuzawa, K. M., Nonogaki, S., Osinaga, E., Umezawa, K., Carvalho, M. A., Verinaud, L. M. C., & Chammas, R. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111592 · Cited by 72
Wang, Y., Yun, Y., Wu, B., Wen, L., Wen, M., Yang, H., Zhao, L., Liu, W., Huang, S., Wen, N., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10103 · Cited by 76
Rey, M. J. D., Valín, Á., Usategui, A., García‐Herrero, C. M., Sánchez‐Aragó, M., Cuezva, J. M., Galindo-Izquierdo, M., Bravo, B., Cañete, J. D. D., Blanco, F. J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03921-4 · Cited by 81
Amini, M. A., Abbasi, A. Z., Cai, P., Lip, H., Gordijo, C. R., Li, J., Chen, B., Zhang, L., Rauth, A. M., & Wu, X. Y. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy131 · Cited by 75
Chang, W. H., Forde, D., & Lai, A. G. (2019) · 癌症:英文版 · doi:10.1186/s40880-019-0369-5 · Cited by 76
Synthetic memory circuits for tracking human cell fate
Burrill, D. R., Inniss, M. C., Boyle, P. M., & Silver, P. A. (2012) · Genes & Development · doi:10.1101/gad.189035.112 · Cited by 70
Role of cytoplasmic lncRNAs in regulating cancer signaling pathways
Fu, P., Zheng, X. M., Xiao, F., & Lin, A. (2019) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1800254 · Cited by 73
Liu, H., Jiang, W., Wang, Q., Hang, L., Wang, Y., & Wang, Y. (2019) · Biomaterials Science · doi:10.1039/c9bm00634f · Cited by 73
Chang, W. H., & Lai, A. G. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14170 · Cited by 75
Tian, Y., & Guo, W. (2020) · Medical Science Monitor · doi:10.12659/msm.920957 · Cited by 78
The Emerging Application of Itaconate: Promising Molecular Targets and Therapeutic Opportunities
Lin, J., Ren, J., Gao, D. S., Dai, Y., & Yu, L. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.669308 · Cited by 76
PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma
Leung, C. O.-N., Wong, C. C.-L., Fan, D. N.-Y., Kai, A. K.-L., Tung, E. K.-K., Xu, I. M.-J., Ng, I. O.-L., & Lo, R. C.-L. (2015) · Oncotarget · doi:10.18632/oncotarget.3534 · Cited by 70
Liu, J., Li, Y., Chen, S., Lin, Y., Lai, H., Chen, B., & Chen, T. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00838 · Cited by 84
Metabolic flexibility and cell hierarchy in metastatic cancer
Berridge, M. V., Herst, P. M., & Tan, A. S. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.08.002 · Cited by 77
Li, C., Xia, J., Wei, X., Yan, H., Si, Z., & Ju, S. (2010) · Advanced Functional Materials · doi:10.1002/adfm.201000038 · Cited by 70
Oncogenic Viruses and Tumor Glucose Metabolism: Like Kids in a Candy Store
Noch, E., & Khalili, K. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0517 · Cited by 77
Wang, Y., Liu, Z., Wang, H., Meng, Z., Wang, Y., Miao, W., Li, X., & Ren, H. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.05.009 · Cited by 70
BNIP3 is degraded by ULK1-dependent autophagy via MTORC1 and AMPK
Park, C. W., Hong, S. M., Kim, E., Kwon, J. H., Kim, K., Nam, H. G., & Choi, K. Y. (2013) · Autophagy · doi:10.4161/auto.23072 · Cited by 71
Lee, S. Y., Ju, M. K., Jeon, H. M., Lee, Y. J., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1027453 · Cited by 71
Chen, Y., Bei, J., Liu, M., Huang, J., Xie, L., Huang, W., Cai, M., Guo, Y., Lin, L., & Zhu, K. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.06.001 · Cited by 70
Lewerenz, J., Sato, H., Albrecht, P., Henke, N., Noack, R., Methner, A., & Maher, P. A. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.165 · Cited by 76
Laurenti, G., Benedetti, E., D’Angelo, B., Cristiano, L., Cinque, B., Raysi, S. D., Alecci, M., Cerù, M. P., Cifone, M. G., Galzio, R. J., et al. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23323 · Cited by 71
Lu, Y., Wang, B., Shi, Q., Wang, X., Wang, D., & Zhu, L. (2016) · Scientific Reports · doi:10.1038/srep39123 · Cited by 76
Savic, L. J., Schobert, I. T., Peters, D. C., Walsh, J. J., Gaupp, F. M. L., Hamm, C. A., Tritz, N., Doemel, L. A., Lin, M., Sinusas, A. J., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1702 · Cited by 74
Weijer, R., Broekgaarden, M., Krekorian, M., Alles, L. K., van Wijk, A. C., Mackaaij, C., Verheij, J., van der Wal, A. C., van Gulik, T. M., Storm, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6490 · Cited by 67
“HIF-1 is constitutively active in most tumors since the tumor growth rate exceeds the rate of neoangiogenesis [21, 23].”
BackgroundInsulin Induces REDD1 Expression through Hypoxia-inducible Factor 1 Activation in Adipocytes
Regazzetti, C., Bost, F., Le Marchand-Brustel, Y., Tanti, J.-F., & Giorgetti-Peraldi, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047688 · Cited by 57
Dormancy of Cancer Cells with Suppression of AKT Activity Contributes to Survival in Chronic Hypoxia
Endo, H., Okuyama, H., Ohue, M., & Inoue, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098858 · Cited by 71
Warrington, J. P., Csiszar, A., Johnson, D. A., Herman, T. S., Ahmad, S., Lee, Y. W., & Sonntag, W. E. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01024.2010 · Cited by 62
Li, Q., Wei, P., Wu, J., Zhang, M., Li, G., Li, Y., Xu, Y., Li, X., Xie, D., Cai, S., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0469-8 · Cited by 67
Role of Mitochondrial Stress Response in Cancer Progression
Lee, Y. G., Park, D. H., & Chae, Y. C. (2022) · Cells · doi:10.3390/cells11050771 · Cited by 72
Seebacher, N. A., Richardson, D. R., & Jansson, P. J. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13079 · Cited by 67
Eckert, A. W., Kappler, M., Schubert, J., & Taubert, H. W. (2012) · Oral and Maxillofacial Surgery · doi:10.1007/s10006-012-0335-8 · Cited by 71
Metadata
- Authors
- Denko, N. C.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Denko, Nicholas C.
- ORCID
- Denko, Nicholas C.
- Venue
- Nature Reviews Cancer
- Published
- 2008-08-14
- Volume
- 8
- Issue
- 9
- Pages
- 705-713
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2066379425
- Cited by
- 1,707
- References
- 126
- Citations by year
- 2026: 48 · 2025: 60 · 2024: 93 · 2023: 113 · 2022: 141 · 2021: 149 · 2020: 115 · 2019: 120 · 2018: 126 · 2017: 94 · 2016: 115 · 2015: 78 · 2014: 95 · 2013: 79 · 2012: 77
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (P01CA067166)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- hypoxia, HIF-1, glucose metabolism, solid tumors, aerobic glycolysis, Warburg effect, cancer metabolism, mitochondrial activity, tumor growth
- MeSH terms
- Cell Division, Glucose, Glycolysis, Humans, Mitochondria, Models, Biological, Neoplasms, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Reactive Oxygen Species, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.